Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Returns
Return on equity-43.6%-66.9%
Return on assets-39.5%+51.9pp-54.9%+186pp-66.5%+120pp-110.7%+93.7pp-91.4%+42.4pp
Liquidity
Current ratio17.2×+12.6×10.7×+9.0×8.3×+6.0×4.9×+3.9×4.6×+3.2×
Quick ratio17.2×+12.6×10.7×+9.0×8.3×+6.0×4.9×+3.9×4.6×+3.2×
Cash ratio16.6×+12.5×10.2×+8.8×7.5×+5.5×4.2×+3.5×4.1×+2.8×
Leverage
Debt-to-equity0.0×-0.1×
Debt-to-assets0.0×0.0×0.0×0.0×0.0×
Interest coverage-15.7×+19.1×-20×+29.8×-27.1×+39.5×-29.4×-34.8×
Per Share
Book value per share$0.62+96.9%$0.65+320%$0.42+80.8%$0.27+425%$0.32+46.4%
Valuation
Market capitalization$759.63M+674%$537.01M+634%$201.22M+150%$176.61M+157%$98.11M+76.2%
Enterprise value$653.41M+826%$466.22M+673%$157.4M+163%$152.05M+152%$70.59M+85.3%
Price / book7.1×+3.5×7.6×-0.2×4.4×6.8×3.5×
Earnings yield-3.9%+23.8pp-5%+37.2pp-12.9%+27.2pp-14.9%+35.2pp-27.6%+36.6pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are SELLAS Life Sciences Group, Inc.'s profit margins?
SELLAS Life Sciences Group, Inc. (SLS) runs a 90.0% gross margin and a -4195.0% operating margin, with a -4130.1% net margin.
Where do SELLAS Life Sciences Group, Inc.'s ratios come from?
Every ratio is computed from SELLAS Life Sciences Group, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.